(Q34027322)

30 July 2017

1 reference

title

Effect of lipid-lowering therapy on vasomotion and endothelial function (English)

1 reference

30 July 2017

0 references

Kinlay S

1

1 reference

30 July 2017

Plutzky J

series ordinal

2

1 reference

30 July 2017

publication date

1 September 1999

1 reference

Current cardiology reports

30 July 2017

published in

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

238-243

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

30 July 2017

cites work

1 reference

12 December 2020

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

12 December 2020

Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate

1 reference

12 December 2020

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

12 December 2020

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical

1 reference

12 December 2020

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

12 December 2020

Role of endothelial dysfunction in coronary artery disease and implications for therapy

1 reference

12 December 2020

Vascular endothelial cells synthesize nitric oxide from L-arginine

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Atherosclerotic plaque rupture: emerging insights and opportunities

1 reference

12 December 2020

Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart

1 reference

12 December 2020

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions

1 reference

12 December 2020

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

1 reference

12 December 2020

Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans

1 reference

12 December 2020

Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group

1 reference

12 December 2020

Endothelium-dependent inhibition of platelet aggregation

1 reference

12 December 2020

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

12 December 2020

In vivo EDRF activity influences platelet function

1 reference

12 December 2020

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

12 December 2020

Can atherosclerotic plaques regress? Anatomic and biochemical evidence from nonhuman animal models

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points

1 reference

12 December 2020

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

12 December 2020

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

12 December 2020

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

12 December 2020

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

12 December 2020

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

12 December 2020

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

1 reference

12 December 2020

Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis

1 reference

12 December 2020

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

12 December 2020

Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1

1 reference

12 December 2020

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

1 reference

12 December 2020

Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate

1 reference

12 December 2020

Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells

1 reference

12 December 2020

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

1 reference

12 December 2020

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

12 December 2020

Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis

1 reference

12 December 2020

Inhibitors of fibrinolysis are elevated in atherosclerotic plaque

1 reference

12 December 2020

Nitric oxide: an endogenous modulator of leukocyte adhesion

1 reference

12 December 2020

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

12 December 2020

Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise

1 reference

12 December 2020

Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis

1 reference

12 December 2020

Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells

1 reference

12 December 2020

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease

1 reference

12 December 2020

Nitric oxide regulates monocyte chemotactic protein-1

1 reference

12 December 2020

Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase

1 reference

12 December 2020

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

1 reference

12 December 2020

Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse

1 reference

12 December 2020

Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.

1 reference

12 December 2020

Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.

1 reference

12 December 2020

10.1007/S11886-999-0029-5

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1007250568

0 references

1 reference